Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Longevity Health Holdings ( (XAGE) ) is now available.
On March 13, 2026, Longevity Health Holdings agreed to sell 689,656 common shares in a $200,000 private placement to International Capital Partners LLC, a vehicle tied to investor-executive Janakiram (Ram) Ajjarapu, with the deal closing on March 16, 2026 and proceeds earmarked for working capital and general corporate purposes. The transaction gives Ajjarapu a meaningful equity stake and was accompanied by his appointment as chairman and chief executive, positioning the company to pursue an acquisition-led growth strategy while it prepares a resale registration for the new shares and manages governance changes, including the mutually agreed March 16, 2026 departure of former CEO and chair Rajiv S. Shukla, who remains a significant shareholder and advisor under a severance arrangement.
Under a March 13, 2026 separation agreement, Shukla relinquished all current and future equity awards in exchange for up to 18 months of severance and a potential cash bonus tied to future capital-raising, while committing to assist the company during the transition. Ajjarapu’s dual role as lead investor and top executive, combined with his background in scaling and acquiring businesses, underscores a shift in strategic direction for Longevity Health Holdings as it seeks to build an acquisition platform in the competitive U.S. bio‑aesthetics market.
More about Longevity Health Holdings
Longevity Health Holdings, Inc. is a bio‑aesthetics company focused on longevity and healthy aging, offering two cosmetic product lines, Elevai Exosomes and Carmell Secretome, that support skin and hair health. It markets its professional-grade skincare and haircare products in the United States through business-to-business, direct-to-consumer and distributor channels, targeting both professional care providers and retail consumers.
Average Trading Volume: 2,819
Technical Sentiment Signal: Sell
Current Market Cap: $712.7K
Find detailed analytics on XAGE stock on TipRanks’ Stock Analysis page.